Sigma-Aldrich
BRADYZIDE (C005B-100533)
Biochem/physiol Actions Potent, orally active, non-peptide B 2 bradykinin receptor antagonist. Features and Benefits This compound was developed by Novartis .
Description
Biochem/physiol Actions
Potent, orally active, non-peptide B2 bradykinin receptor antagonist.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Specifications
- UPC:
- 51151640
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- Quantity:
- 5
- Unit of Measurement:
- MG
- MPN:
- B1680-5MG
Catalog No.
C005B-100533
-
Fast shipping — 3-day lead time
-
Guaranteed quality & reliable delivery
-
Shipping Lead-Time: 3-5 Days
